As the life sciences’ cluster organization for London and the greater south east, MedCity continues work to strengthen ties between our region and networks from the sector around the world.

The Mayor of Seoul, Park Won-soon, met with our CEO Sarah Haywood in London this month to sign an MoU to support collaboration between our mutual bioscience sectors. This follows a recent trip to Seoul by our Director of International Projects, Phil Jackson, for a symposium organised in partnership with the Korean Pharma and Bio-Pharma Manufacturing Association.

The MoU, signed at Imperial White City between MedCity and the Mayor of Seoul, sets out an agreement for both parties to work to expand scientific exchanges and networking programs in the sector. The occasion, part of Won-soon’s wider tour and meeting with our own Mayor of London, was also a great opportunity for Korean students and start-ups working at the impressive White City campus to meet the visiting delegation.

Partnerships with life sciences’ communities beyond the UK play an important role in supporting innovation within our own health and care system. We know that ultimately, we’re all working on finding solutions to similar problems, and there are fantastic international companies out there looking to bring their innovations to the UK.

The government in South Korea is increasing investment into its biotech sector, pledging US$2.60 billion in funding this year as part of its 2019 Biotechnology Promotion Plan. A new biotech hub in Seoul will support the development of technology innovation and establish a platform to utilize big data in health care.

Interested in opportunities in the Asian Life Sciences sector? Join us at BioJapan 2019 this October!

To find out more, contact us at office@medcityhq.com